Your browser doesn't support javascript.
loading
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma.
Song, Shumei; Xie, Min; Scott, Ailing W; Jin, Jiankang; Ma, Lang; Dong, Xiaochuan; Skinner, Heath D; Johnson, Randy L; Ding, Sheng; Ajani, Jaffer A.
Afiliação
  • Song S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ssong@mdanderson.org jajani@mdanderson.org.
  • Xie M; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California.
  • Scott AW; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jin J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ma L; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dong X; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Johnson RL; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ding S; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California.
  • Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ssong@mdanderson.org jajani@mdanderson.org.
Mol Cancer Ther ; 17(2): 443-454, 2018 02.
Article em En | MEDLINE | ID: mdl-29167315

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fosfoproteínas / Neoplasias Esofágicas / Adenocarcinoma / Proteínas Adaptadoras de Transdução de Sinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fosfoproteínas / Neoplasias Esofágicas / Adenocarcinoma / Proteínas Adaptadoras de Transdução de Sinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article